Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies for immuno-oncology and immuno-inflammation, leveraging microbiome-associated mechanisms to regulate innate immune responses
Exeliom Biosciences is a clinical-stage biotechnology company developing next-generation immunotherapies for immuno-oncology and immuno-inflammation, leveraging microbiome-associated mechanisms to regulate innate immune responses.